Danuta Herzyk is the program committee chair for the 2014 meeting and each program committee member is expected to submit a suggested program proposal. I am pleased to announce that our proposal to SOT for joint programming with the Japanese Society of Immunotoxicology for the [2012] [2013] International Exchange Program has been approved by the Global Initiatives Committee of SOT. We have been awarded matching funds ($2000) in support of our initiatives with JSIT. Most recently, Henk van Loveren and Emanuela Corsini spoke in September at the 19 th Annual Meeting of JSIT on "Overview and Application of the WHO/IPCS Harmonized Guidance for Immunotoxicity: Risk Assessment for Chemicals" and "Current Trend on In Vitro Immunotoxicology in EU", respectively.
As noted in the last newsletter, one idea for SS is to put a proposal forward for an SOT Contemporary Concepts in Toxicology (CCT) meeting around immunotoxicology. CCT meetings are one-to two-day focused, open registration, scientific meetings in contemporary and rapidly progressing areas of toxicological sciences.
As we begin 2013, please don't forget some key upcoming events: 1) to begin the planning of scientific session submissions for the 2014 SOT meeting in Phoenix, Arizona; 2) to nominate individuals for awards and leadership roles in the SS; and 3) to renew your SS membership.
SOT will underwrite all the liabilities of the CCT meeting with the expectation that the meeting will at least break even financially. SOT will provide $25,000 in seed funds. Once the meeting breaks even, there is the opportunity for profit sharing of the additional revenue with our specialty section. CCT proposal details are available at www.toxicology.org/ai/meet. I would like to form a small but diverse ad hoc committee to work on this goal in 2013. A CCT meeting on Autoimmunity and Hypersensitivity is being proposed. If you are interested in working on this CCT proposal, please send me a note at Gregory.s.ladics@usa.dupont.com.
I look forward to seeing everyone at the SOT Meeting in March in San Antonio. A formal call for nominees will come at a later date. 
ATTENTION GRAD STUDENTS!

Submitted by: Henk van Loveren, PhD and Emanuela Corsini, PhD
Emanuela Corsini and Henk van Loveren were invited to represent the Immunotoxicology Speciality Section of the SOT at the Annual Meeting of the Japanese Society of Immunotoxicology, held in Tokyo on 15 and 16 September, 2012. The meeting, aimed at "novel aspects of immunotoxicological diseases" was impressive in the sense that there was quite a large group of scientists from Japan who are active members of this Society. Most lectures were in Japanese, so it was a bit difficult to follow the presentations, but looking at the slides one got the impression of the advancements made and the real focus on mechanistic research.
Henk van Loveren presented a lecture entitled "Overview and Application of the WHO/IPCS Harmonized Guidance for Immunotoxicity Risk Assessment for Chemicals" and Emanuela Corsini presented a lecture entitled "Current trend on in vitro immunotoxicology in Europe."
Both lectures were well received as they were to a certain extent on a different level than most other presentations, i.e. alternatives for animal testing and on risk assessment. The seminars well complemented the series of lectures within the meeting.
Update on Japanese Society of Immunotoxicology Meeting
Call for Nominations from the Awards Committee
Submitted by: Jean Pfau, PhD
Recognizing the scientific contributions of our students and colleagues is, in my opinion, one of the most important things we do. It not only recognizes them, but also publicizes the accomplishments of our Specialty Section toward the mission of SOT. The Awards Committee strongly encourages you to nominate your colleague(s), including self-nominations, for the various awards presented by the Immunotoxicology Specialty Section. We hope to continue to see the same high quality of nominees that challenges the Committee to choose among our very best! This fellow will participate in a research program that is evaluating novel approaches (toxicogenomics, plethysmography) anchored to airway epithelial remodeling (quantitative morphometry) for assessing the respiratory sensitization and allergy potential of various chemicals and proteins.
The individual will be expected to publish their research in peer reviewed journals.
Qualifications
A PhD in Pharmacology or Toxicology with an emphasis in immunotoxicology, allergy, asthma, respiratory physiology & toxicology or animal models of chronic respiratory disease is highly preferred. Other related scientific disciplines will be strongly considered (e.g., immunology, respiratory or pulmonary toxicology, etc.).
Strong written and oral communication skills that allow dissemination of complex technical issues in a clear, concise manner are required.
The following skills and/or experiences will be highly sought after: Laboratory experience in one or more of the following areas: immunotoxicology, molecular biology (genomics), allergy, asthma, respiratory physiology and toxicology, and/or animal models of chronic respiratory disease. Experience working with inhalation exposure equipment Experience with immune assays Demonstrated ability to work independently. Please apply at: https://dow.taleo.net/careersection/10020/jobdetail.ftl?job=1210547 
POST DOC POSITION ANNOUNCEMENT!
SAVE THE DATE!
